Day by day, at least for the first few hours of trading, the penny stock of Biozoom, Inc. (BIZM), creators of the world’s first handheld, non-invasive mobile health monitor for measuring biofeedback in humans, is seeing increased volume and showing nothing but green. BIZM stock has been quietly showing signs that reversing into the shell of Entertainment Art, Inc. (EERT) was only the beginning. With a Carl Ziess designed lens and pre-orders being taken on their website, soon everyone will be able to tell what the hell is wrong with themselves by just the touch of a button and access to a smartphone – genius!
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
BIZM Stock Quote
Market Cap: 86.01M
Last: 1.44 ▲ 0.04 (+2.86%)
Dollar volume: $403,965
Issued and Outstanding: 59,730,000
Wolfgang Koecher: 17,635,800
Hardy Hoheisel: 17,635,800
1st Resistance Point: 1.4533
2nd Resistance Point: 1.4667
1st Support Level: 1.4133
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
Having already begun clinical trials of their handheld device which utilizes spectroscopy, the interaction between cells and radiated energy, to measure concentrations of substances in the medical and chemical industry, Biozoom is quickly becoming a must own penny stock. With just 20 million shares to go around, BIZM stock has been seeing daily doubles to its previous day’s volume in 4 of the last 5 trading sessions.
While they are obviously catering to the German clientele to get into BIZM stock long and strong, Biozoom’s website is extremely informative and descriptive when it comes to making it simple to understand why this device could become the household thermometer of the 21st century. Although a hotter spokes model could have helped to sell the sizzle, the “Carl Ziess” lens notated on the Biozoom device supports the theory that a picture is worth a thousand words.
Although the majority of Biozoom is made up primarily of intellectual property, patents, patent applications, provisional patents and/or applications, trademarks, tradenames, license or sub license rights, developments, ideas, drawings, concepts, copyrights, technologies, formulas, developments, trade secrets, ideas, there is some substance as to what they are putting together.
Last month, Biozoom signed Prof. Dr. Hasan Mukhtar to a consulting agreement to provide consulting services related to the field of dermatology up to 12 days per year. One week later, the Company brought in Prof. Dr. Rudolf Kessler to do the same in the fields of spectroscopy and multivariate data analysis, soon followed by Prof. Dr. Leonard Zastrow to, again, do the same in the field of cosmetics (specifically the use of antioxidants in cosmetics, including in anti-aging and sunscreen cosmetics).
The list reads like a who’s-who of celebrated scientists.
Be it as it may, but as far as hot biotech stocks go that cross over into the technology sector, Biozoom looks like its covering all its bases and setting BIZM stock up for a summer run.
About BIZM Stock
Biozoom, Inc. is a development stage company that holds certain patents and licenses to technology in the field of devices that use spectroscopics to detect and measure substances within the body or other biological substances.
Click here to view the SEC filings for BIZM.
Click here to view the website for Biozoom.
First 4 Trading Sessions:
Stay Connected With Us:
If it isn’t already there, BIZM is a required addition to the list of penny stocks to go mid- to long-term on. With so few shares out there in the public float and already trending positively for over a week, BIZM could easily scratch the surface of $2 before most Americans even realize summer has started.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share